Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
Errors and Resolutions in the Use of the COVID-19 Vaccine
TOP STORIES — Diabetes News and Research
Cause-Specific Mortality Due to Hypoglycemia
The Role of Dapagliflozin in Patients with Type 2 Diabetes and Atrial Fibrillation
Glycemic Benefit of Weekly GLP-1 Agonist: Albiglutide
MOST POPULAR ARTICLES OF THE MONTH
#1 Omnipod Horizon System in Children with Type 1 Diabetes
#2 Daily Pill Optimizes Insulin Use and Reduces A1c For Type 1 Diabetes
#3 Sure, You May Lose Weight, But Will Going Low-Carb Impact Your Performance?
Letter from the Editor
There is no doubt that some companies are benefiting from the current pandemic. I am not saying they are gouging patients, but just that the opportunity to market products like PPE and ventilators and supplies is driving giant sales. In addition, if your company happens to have an approved virus vaccine like Pfizer, or a therapy to reduce COVID severity like Gilead, your sales will be through the roof. But what about the rest of Pharma and all the medications for chronic diseases, like hypertension or diabetes, or asthma?
We know that many patients are either stretching their medications or stopping them all together. This has evidently had an effect on the bottom lines of some large pharma companies. Most companies raise their prices every January, and today it was announced that drug prices for already marketed drugs had increased more than in the past 5 years, and more companies than ever announced price increases.
This all means our jobs will be a little harder, and I encourage all of you to help your patients by going the extra step to do the prior authorizations when needed, and using manufacturer buy down programs when possible.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
As the new vaccines for COVID-19 are rolled out, the Institute for Safe Medication Practices (ISMP) has called attention to some of the missteps in vaccine administration that have occurred, and offers safe practice recommendations.
TOP STORIES — Diabetes News and Research
A retrospective observational study seeks to determine absolute risk of death due to CVD, cancer, and other causes in patients who experienced a severe hypoglycemic event.
A post hoc analysis of the DECLARE-TIMI 58 trial may provide a new compelling indication for dapagliflozin.
Simple add-on therapy can reduce insulin use for patients with type 2 diabetes.